W. Richard Burack, M.D., Ph.D.

W. Richard Burack, M.D., Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester, NY 14642

Office: (585) 273-1885
Fax: (585) 276-2390

Research Bio

Dr. Burack's research interests include the molecular mechanisms of lymphoma progression and development of molecular methods to refine diagnostics particularly of lymphomas and leukemias.

Awards & Honors (Local)

Eric A. Schenk Award for Excellence in Teaching | Pathology and Laboratory Medicine | University of Rochester School of Medicine and Dentistry 2014
Excellence in 2nd Year Teaching | University of Rochester School of Medicine 2010
Class of 2010 Professor of the Year | Washington Univ School of Medicine 2007
Class of 2009 Professor of the Year | Washington Univ School of Medicine 2006
Class of 2008 Lecturer of the Year | Washington Univ School of Medicine 2005
Class of 2006 Distinguished Teacher Award | Washington Univ School of Medicine 2004

Recent Journal Articles

Showing the 5 most recent journal articles. 35 available »

2014 Aug
Friedberg JW, Unger JM, Burack WR, Gopal AK, Raju RN, Nademanee AP, Kaminski MS, Li H, Press OW, Miller TP, Fisher RI. "R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433." British journal of haematology.. 2014 Aug; 166(3):382-9. Epub 2014 Apr 18.
2014 Apr 18
Subik MK, Herr MM, Hutchison RE, Kelly J, Tyler WK, Merzianu M, Burack WR. "A highly curable lymphoma occurs preferentially in the proximal tibia of young patients." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2014 Apr 18; Epub 2014 Apr 18.
2014 Jan 1
Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos I, Agarwal AB, Jung J, Burack R, Zhou X, Leonard EJ, Fingert H, Danaee H, Bernstein SH. "Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 Jan 1; 32(1):44-50. Epub 2013 Sep 16.
2014
Brown JT, Burack WR, Becker MW, Vlad-Vonica R, Nadasdy T, Bennett JM, Mendler JH. "Extracellular crystals in plasma cell myeloma." Leukemia research reports.. 2014 3(2):49-50. Epub 2014 Jun 18.
2013 Jun
Bernstein SH, Epner E, Unger JM, Leblanc M, Cebula E, Burack R, Rimsza L, Miller TP, Fisher RI. "A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213." Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Jun; 24(6):1587-93. Epub 2013 Mar 15.

Current Appointments

Director, Hematopathology Unit - Department of Pathology and Laboratory Medicine (SMD)
Associate Professor - Department of Pathology and Laboratory Medicine (SMD) - Primary
Associate Professor - Cancer Center

Specialties

Hematology - American Board of Pathology
Clinical Pathology/Laboratory Medicine - American Board of Pathology

Education

MD | Medicine | Univ of Virginia Sch Medicine1995
PhD | Molecular Biophysics | Univ of Virginia Sch Medicine1994
BS | Biochemistry | Canada-McGill University1986

Post-Doctoral Training & Residency

Fellowship in Pathology at Barnes-Jewish Hospitals07/01/1998 - 06/30/1999
Residency in Clinical Pathology at University of Virginia School of Medicine07/01/1995 - 06/30/1998